Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of mupirocin 2% gel (Impetine) versus mupirocin 2% ointment (Baitoubang) in impetigo
CTR20230116Phase 3Completed
- Sponsor
- Laboratorio Reig Jofre, S.A.
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Impetine in impetigo, sponsored by Laboratorio Reig Jofre, S.A.. Started Apr 2023; status: completed.
02
Drugs
Impetine
03
Conditions
impetigo
Beyond the preview
Go deeper on CTR20230116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230116.